Wednesday, January 26, 2011

U.S. government launches pharmaceutical division


The U.S. government has decided to enter the pharmaceutical business. Apparently, the drug companies aren’t coming out with new “breakthrough” drugs quickly enough, and now the U.S. government plans to spend taxpayer dollars conducting research on drugs which will be turned over to Big Pharma. Those drug companies, in turn, will sell them for a profit. It’s yet another clear case where the government is taking over the health care (sick care) industry and funneling profits into the hands of pharmaceutical corporations.

This is all happening because drug companies say they’re scaling back their research funding to find new drugs. This terrifies the U.S. government, apparently, which doesn’t recognize that scaling back drug company R&D is actually a good thing for America given how much economic damage and personal health damage is caused each year by Big Pharma’s dangerous drugs. So instead of letting the failing pharmaceutical market contract on its own, Big Government wants to artificially prop it up with taxpayer dollars in much the same way that the feds bailed out Wall Street’s rich banksters with trillions of dollars over the last two years.

The new government drug research center will operate under the National Institutes of Health (NIH) and be called the National Center for Advancing Translational Sciences. Dr. Francis Collins, director of the National Institutes of Health, says he hopes Congress will increase funding of the center to at least $1 billion annually.

No comments:

Post a Comment